Cytokinetics, Inc. (ZB_8994.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Inc. | Nasdaq: | Nasdaq CYTK stock forecast for 2023 – 2027. Last updated: November 14, 2023. Cytokinetics, Incorporated. 32.44 D 2.40% (0.76) Are you interested in Cytokinetics, Incorporated stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYTK stock price in 2022-2027. Is CYTK a good long term …Cytokinetics, Incorporated (KK3A.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | BOERSE MUENCHEN ...Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by UBS on January 24, 2024. Buy Rating for Cytokinetics Supported by Strong Trial Results and ... B.Riley Financial also maintained a Buy rating on the stock with a $122.00 price target. See the top stocks recommended by ...Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …Cytokinetics will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Cytokinetics’ election. The initial conversion rate is 19.5783 shares of common stock per $1,000 principal amount of notes, which represents an initial conversion price …Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. This indicates that the analyst believes the stock is currently undervalued and has the potential for price appreciation, with a specific target of $66.00. When looking at the average twelve-month price prediction for Cytokinetics, it stands at $58.64. However, there is also a high price target of $80.00 and a low price target of $42.00.With Cytokinetics stock trading at $84.12 per share, the total value of Cytokinetics stock (market capitalization) is $8.25B. Cytokinetics stock was originally …Dec 27, 2023 · The shares rose as much as 83% at the New York market open, the most intraday since they began trading in 2004. Cytokinetics had a market value of more than $4.4 billion before the surge, and ... Amgen Inc. -0.99%. $164.04B. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Cytokinetics’ share price fell 16% yesterday on news that Novartis has dropped its pursuit of the biotech. ... One problem for potential buyers is the phase 3 data sent the stock into overdrive.Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …Historical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of February 19, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide</a>.2 days ago · What is the target price for Cytokinetics (CYTK) stock? A. The latest price target for Cytokinetics ( NASDAQ: CYTK) was reported by UBS on Wednesday, January 24, 2024. The analyst firm set a price ... Amgen Inc. -0.99%. $164.04B. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.-64.19(-0.17%) Nasdaq -144.87(-0.92%) Russell 2000 -28.60(-1.41%) -0.92(-1.16%) Gold +11.60(+0.57%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time …Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or monthly format back to when Cytokinetics, Incorporated stock was issued. Cytokinetics Inc stock is currently priced at $76.89, with a 24-hour trading volume of 1.32M. It has seen a -2.13% decreased in the last 24 hours and a -5.30% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $77.77 pivot point. If it approaches the $76.83 support level, significant changes may ...CYTK Cytokinetics · High. 79.590 · Low. 76.780 · Volume. 1.32M · Open. 78.460 · Pre Close. 78.560 · Turnover. 102.80M · Turnover Ra...Get the latest information on Cytokinetics, Incorporated Common Stock (CYTK) including its bid and ask prices, market cap, news and history. See how CYTK performed on Nasdaq and other global markets. Cytokinetics (CYTK) delivered earnings and revenue surprises of -87.50% and 98.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks. Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert I. Blum sold 12,500 shares of the company's stock in a transaction on Friday, January 19th.The stock was sold at an average price of $81.42, for a total value of $1,017,750.00. Following the sale, the chief executive officer now directly owns 441,797 shares in the …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.According to the current price, Cytokinetics is 292.92% away from the 52-week low. What was the 52-week high for Cytokinetics stock? The high in the last 52 weeks of …CYTK: Lowering target price to $30.00. (Argus Research) Apr-20-23 04:00PM. Cytokinetics to Announce First Quarter Results on May 4, 2023. (GlobeNewswire) Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people ... The South San Francisco-based company has attracted interest from at least one major drugmaker in recent months, Bloomberg News reported in October. Shares of Cytokinetics rose as much as 20% in ...Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52.The stock extended its rally into 2024 despite markets struggling in the new year. ... CYTK Price Action: Shares of Cytokinetics were down 6.48% at $101.06 at the time of publication, ...Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Dec 27, 2023 · However, the average price target of $61.07 is “outdated” due to the dramatic pop today. JPM Securities’ Jason Butler anticipates CYTK hitting $110 per share, translating to roughly 36% ... The intrinsic value of one CYTK stock under the Base Case scenario is 16.76 USD. Compared to the current market price of 76.89 USD, Cytokinetics Inc is ...Cytokinetics, Inc. Stock price Nasdaq Equities US23282W1009 Biotechnology & Medical Research End-of-day quote Nasdaq. Other stock markets-USD 0.00%: Feb. 13 ...View, at a glance, the 52-Week High and Low for a symbol, along with the 61.8%, 50%, and 38.2% Fibonacci levels. These figures correspond to the information presents on the Trader's Cheat Sheet page. The historical data and Price History for Cytokinetics (CYTK) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download.Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CYTK support price is $34.79 and resistance is $37.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYTK stock will trade within this expected range on the day. View …The ups and downs of stock prices are often likened to a roller-coaster ride—and this past month, investors in Cytokinetics (CYTK) have seen all too well the ups, and the downs, of that metaphor ...Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsDecember 29, 2023. Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Free Report) rose 2.1% on Friday after StockNews.com upgraded the stock from a sell rating to a hold rating. The company traded as high as $85.50 and last traded at $85.01. Approximately 1,276,714 shares traded hands during mid-day trading, an increase of 2% from the average ...Cytokinetics, Incorporated Common Stock (CYTK) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.Cytokinetics, Incorporated (KK3A.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Deutsche Boerse ...MT. UBS Downgrades Cytokinetics to Neutral From Buy, Adjusts Price Target to $92 From $61. Jan. 24. MT. Mizuho Securities Boosts Price Target on Cytokinetics to $103 From …View live Cytokinetics, Incorporated chart to track its stock's price action. Find market predictions, CYTK financials and market news. Corporate Presentation. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. See the company profile for Cytokinetics, Incorporated (CYTK) including business summary, ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 76.89-1.67 (-2 ...Related news How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it ...Cytokinetics’ share price fell 16% yesterday on news that Novartis has dropped its pursuit of the biotech. ... One problem for potential buyers is the phase 3 data sent the stock into overdrive.Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...View live Cytokinetics, Incorporated chart to track its stock's price action. Find market predictions, CYTK financials and market news. Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.In another report released on October 30, J.P. Morgan also maintained a Buy rating on the stock with a $48.00 price target. ... Cytokinetics price target lowered to $48 from $54 at JPMorgan;Corporate Presentation. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Cytokinetics, Incorporated (KK3A.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Berne S.E.: KK3A ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...View Cytokinetics, Incorporated CYTK investment & stock information. Get the latest Cytokinetics, Incorporated CYTK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsView CYTK price history, and other historical data. Get the latest Cytokinetics Inc (CYTK) stock price, news, analysis, and research in Stockscan.io.Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 81.87 +0.62 (+0.76%) At close: 04:00PM EST. 79.95 -1.92 ( …Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.1 Data adjusted for splits and stock dividends. 2 2022 Calculation Operating profit per share = Operating loss ÷ No. shares of common stock outstanding = -324,202,000 ÷ 95,161,391 = -3.41. 3 Closing price as at the filing date of Cytokinetics Inc. Annual Report. 4 2022 Calculation P/OP ratio = Share price ÷ Operating profit per share = 43.11 ...The potential price and other terms couldn’t be learned. Cytokinetics is focused on so-called muscle activators and inhibitors as ... The Motley Fool: Epic Bundle - 3x Expert Stock ...Shares of Cytokinetics with a market capitalization of over $9 billion, as of Friday's closing price, have more than tripled in value since Oct. 31, when reports of the company attracting takeover ...3 days ago · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 Week Low: US ... Market capitalization of Cytokinetics (CYTK). Market cap: $7.65 Billion. As of ... Stock prices are delayed, the delay can range from a few minutes to several ...Dec 27, 2023 · Get the latest Cytokinetics Incorporated (CYTK) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The stock was also headed for a new record one-day gain since the company went public in April 2004, surpassing the current record of 40.4%, set on July 19, 2021.When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...
View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the .... Real madrid vs union berlin live
Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.3 days ago · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 Week Low: US ... Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or monthly format back to when Cytokinetics, Incorporated stock was issued. Cytokinetics, Incorporated (CYTK.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Nasdaq: CYTK ...Cytokinetics to Announce Fourth Quarter Results on February 27, 2024. Globe Newswire • 10 days ago. Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Research Cytokinetics' (Nasdaq:CYTK) stock key valuation metrics while comparing it with its industry peers & market side by side. Research ... The above table shows the analyst CYTK forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...3 days ago · Rates Futures Crypto Home Investing Quotes Stocks United States CYTK Overview Stock Screener Earnings Calendar Sectors Nasdaq | CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list NEW Set a price... The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. Cytokinetics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.According to 16 analysts, the average rating for CYTK stock is "Strong Buy." The 12-month stock price forecast is $75.31, which is a decrease of -0.37% from the …Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...Adjusted debt-to-capital ratio. A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Cytokinetics Inc. adjusted debt-to-capital ratio deteriorated from 2020 to 2021 and from 2021 to 2022. An indicator of profitability, calculated as adjusted net income divided by total revenue. Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Stock Quote. Stock Information. Stock Quote; Stock Chart; Historical Price Lookup ... posters and/or oral presentations that contain data from Cytokinetics-sponsored ... Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks. View the real-time CYTK price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper ...Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price..